Re-Irradiation of Progressive or Recurrent DIPG

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 15, 2017

Primary Completion Date

November 20, 2024

Study Completion Date

November 25, 2024

Conditions
Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
Interventions
RADIATION

re-irradiation

if DIPG has progressed or recurred at 180 days or later from completion of primary radiation therapy, a second course of radiation therapy will be given

Trial Locations (18)

Unknown

The Children's Hospital at Westmead, Westmead

Queensland Children's Hospital, Brisbane

Monash Children's Hospital, Clayton

Royal Children's Hospital, Parkville

Perth Children's Hospital, Perth

Stollery Children's Hospital, Edmonton

BC Children's Hospital, Vancouver

Janeway Child Health Centre, St. John's

IWK Health Centre, Halifax

McMaster Children's Hospital, Hamilton

Children's Hospital at London Health Sciences Centre, London

Children's Hospital of Eastern Ontario, Ottawa

The Hospital for Sick Children, Toronto

CHU de Québec-Université Laval, Laval

Centre Hospitalier Universitaire Sainte-Justine, Montreal

Montreal Children's Hospital, Montreal

Starship Hospital, Auckland

T3B 6A8

Alberta Children's Hospital, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT03126266 - Re-Irradiation of Progressive or Recurrent DIPG | Biotech Hunter | Biotech Hunter